Neil Paine looks at five NASCAR Cup Series drivers to see if it's already time for them to panic after four races in the 2026 ...

Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

Pre-configured to identify normal, high-vibration, and unstable motor conditions STMicroelectronics (NYSE:STM)GENEVA, ...

Several EVs are skipping the 2026 model year in the U.S. as automakers reset strategies. Models like the Audi A6 e-tron, Audi Q6 e-tron, Volkswagen ID Buzz, Dodge Charger Daytona R/T, Polestar 2, and ...

Tata Motors PV, with the new Punch EV, is doubling down on entry-level buyers, even as CAFE-III norms promise to rewrite the wider competitive calculus.

See why Trey'Dez Green and Jamari Johnson top our 2026 returning tight end rankings. Comprehensive analysis of the best SEC, Big Ten, and Big 12 stars.

Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants ...

Genethon, a pioneer and leader in gene therapy for rare diseases, unveiled results at the MDA Conference in Orlando confirming the long-term efficacy of its GNT0004 gene therapy in Duchenne muscular ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for isolated dystonia and for Parkinson’s diseaseFirst ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for ...

Project Airstrike is a project collab between Ford Muscle and House of Boost. Here, the 2023 F-150 is boosted by a Stage 2 ...

Early GO decision reached ahead of Q2'26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Key objectives achieved: ...